Skip to main content
. 2018 Apr 3;63(2):154–163. doi: 10.3164/jcbn.18-11

Table 4.

MetS and adenomatous polyps

Categorical variables Men
Women
MetS+ (n = 54) MetS– (n = 90) OR (95% CI) p MetS+ (n = 19) MetS– (n = 68) OR (95% CI) p
Number
 1 13 (24.1) 30 (33.3) 1 11 (58.0) 32 (47.1) 1
 2 9 (16.7) 24 (26.7) 0.86 (0.31–2.35) 0.76* 4 (21.0) 20 (29.4) 0.50 (0.13–1.89) 0.31
 3≤ 32 (59.2) 36 (40.0) 1.84 (0.81–4.22) 0.15* 4 (21.0) 16 (23.5) 0.65 (0.32–1.30) 0.22
p trend 0.05 0.53
Size (mm)
 <5 14 (25.9) 19 (21.1) 1 7 (36.8) 18 (26.5) 1
 5≤ <10 15 (27.8) 44 (48.9) 0.41 (0.16–1.04) 0.06* 8 (42.2) 27 (39.7) 0.69 (0.20–2.35) 0.55
 10≤ 25 (46.3) 27 (30.0) 0.95 (0.37–2.45) 0.92* 4 (21.0) 23 (33.8) 0.55 (0.26–1.15) 0.11
p trend 0.38 0.25
Location
 Proximal colon 29 (53.7) 40 (44.4) 1 10 (52.6) 32 (47.1) 1
 Distal colon 25 (46.3) 50 (55.6) 0.63 (0.31–1.27) 0.19* 9 (47.4) 36 (52.9) 1.09 (0.37–3.22) 0.87
Advanced adenoma
 No 28 (51.8) 63 (70.0) 1 15 (79.0) 43 (63.2) 1
 Yes 26 (48.2) 27 (30.0) 1.95 (0.95–4.02) 0.07* 4 (21.0) 25 (36.8) 0.33 (0.09–1.15) 0.08

MetS, metabolic syndrome. *Adjusted for age (≥65 years) and alcohol drinking. Adjusted for age (≥65 years).